Nephrogenomics, precision medicine and the role of genetic testing in adult kidney disease management
- PMID: 40524009
- DOI: 10.1038/s41581-025-00970-1
Nephrogenomics, precision medicine and the role of genetic testing in adult kidney disease management
Abstract
Genetic investigations in nephrology have long been viewed as the prerogative of paediatricians or restricted to archetypal genetic nephropathies with highly penetrant variants affecting young adults. However, genetic testing has emerged as a pivotal tool in the field of adult nephrology, with the ability to revolutionize the understanding and management of adult kidney diseases. Here, we explore the multifaceted role of genomic testing (such as exome or genome sequencing) in chronic kidney disease, shedding light on current genetic findings for reframing diagnostic paradigms and tailoring treatment strategies. Genomic testing has enhanced our comprehension of kidney diseases of unknown origin by showing that ~20% are attributable to kidney Mendelian genetic disorders with as yet unsuspected phenocopies. Beyond genetic counselling, genetic integration can optimize therapeutic interventions, kidney transplantation and kidney disease prevention, both in index cases and in at-risk family members. Furthermore, the emerging field of rapid nephrogenomics promises streamlined diagnosis and management, with a potential impact on early therapeutic strategy. Importantly, although costs continue to decrease, the integration of genomic technologies in nephrology practice raises several ethical concerns, especially regarding variants of uncertain significance, and incidental or secondary findings. Establishing multidisciplinary frameworks should maximize the potential of nephrogenomics to improve patient outcomes.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: M.D. is employed by Eurofins Biomnis. The other authors declare no competing interests.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Beckwith-Wiedemann Syndrome.2000 Mar 3 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2000 Mar 3 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301568 Free Books & Documents. Review.
-
Cystinosis.2001 Mar 22 [updated 2025 Aug 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2001 Mar 22 [updated 2025 Aug 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301574 Free Books & Documents. Review.
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
Cited by
-
Genetic Kidney Disease Across the Lifespan - Emerging Insights From Clinical Genomics in Older People.Kidney Int Rep. 2025 Jun 30;10(8):2548-2550. doi: 10.1016/j.ekir.2025.06.050. eCollection 2025 Aug. Kidney Int Rep. 2025. PMID: 40814627 Free PMC article. No abstract available.
References
-
- Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142–151 (2019). - PubMed
-
- Claus, L. R., Snoek, R., Knoers, N. V. A. M. & van Eerde, A. M. Review of genetic testing in kidney disease patients: diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups. Am. J. Med. Genet. Part C Semin. Med. Genet. 190, 358–376 (2022). - PubMed
-
- Doreille, A. et al. Exome-first strategy in adult patients with CKD: a cohort study. Kidney Int. Rep. 8, 596–605 (2023). - PubMed
-
- Robert, T. et al. Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. Clin. Kidney J. 17, sfad099 (2024). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical